The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Get Instant Summarized Text (Gist) A key regulator for the GTPase function of the LRRK2 gene, linked to Parkinson's Disease, has been identified. This regulator, CalDAG-GEFI, can control the ...

Idiopathic Parkinson’s disease (IPD ... PN in IPD could substantially contribute to gait disturbance and disability in some patients with IPD, and prevention of PN would be an important advance.

Researchers have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that ...